Haemonetics HAE United States — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's united states — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's united states — net revenues?
- Haemonetics (HAE) reported united states — net revenues of $251.97M in Q1 2026.
- How has Haemonetics's united states — net revenues changed year-over-year?
- Haemonetics's united states — net revenues increased by 1.5% year-over-year, from $248.29M to $251.97M.
- What is the long-term trend for Haemonetics's united states — net revenues?
- Over 4 years (2022 to 2026), Haemonetics's united states — net revenues has grown at a 11.3% compound annual growth rate (CAGR), from $639.32M to $982.18M.
- What does united states — net revenues mean?
- This metric measures the total gross sales generated from products and services within the United States, adjusted for returns, allowances, and discounts. It serves as a primary indicator of market demand, competitive positioning, and commercial success within the company's largest geographic operating region. Tracking this revenue stream is essential for evaluating the company's ability to capture market share and drive growth in its core domestic market.